US equities |
SPCX $167.22 ▲+5.19% NVDA $237.04 ▲+1.32% MU $1,066.44 ▼-0.79% TSLA $375.93 ▲+1.44% MSFT $525.75 ▲+1.59% INTC $116.93 ▼-2.01% SNDK $1,720.70 ▲+0.04% META $742.25 ▲+1.95%
FinancialContent

CVS Health Corp (NY:CVS)

86.96 +0.50 (+0.58%)
Delayed Quote Updated: 10:34 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
72 73 Next >
News headline image
Blue Shield's $500 Million Drug Savings Initiative With Amazon Pharmacy Can Potentially Launch In January ↗
Blue Shield of California launches its Pharmacy Care Reimagined Initiative with Amazon Pharmacy and Abarca in January, aiming to save $500 million annually in drug costs. 
Via Benzinga
News headline image
UnitedHealthcare Faces Scrutiny Amid CEO's Tragic Death, Industry Criticism ↗
UnitedHealthcare's claim denial practices are under scrutiny following the murder of CEO Brian Thompson, with criticism over its profit-driven approach to care. 
Via Benzinga
News headline image
13 Healthcare Sector Stocks With Healthy Valuation ↗
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty... 
Via Talk Markets
Topics Stocks Stocks / Equities
News headline image
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market ↗
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity. 
Via Investor's Business Daily
News headline image
This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
 
Via Benzinga
News headline image
Key Takeaways From CVS Health Analyst Ratings ↗
 
Via Benzinga
News headline image
Is CVS Health Stock a Buy? ↗
Via The Motley Fool
News headline image
CVS Health's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA? ↗
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
News headline image
3 Key Analyst Upgrades: Why These Stocks Are Getting a Boost
Retail investors have a chance to break down the reasons behind the latest analyst upgrades and why they're being made in these three stocks. 
Via MarketBeat
Topics Economy
News headline image
Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too? ↗
Via The Motley Fool
News headline image
Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI ↗
Wedbush Securities has issued an endorsement of the artificial intelligence software sector, with Managing Director Dan Ives predicting that 2025 will be a pivotal year for AI implementation across the... 
Via Benzinga
Topics Artificial Intelligence
News headline image
(CVS) - Analyzing CVS Health's Short Interest ↗
 
Via Benzinga
News headline image
Is CVS Health Stock an Underrated Buy? ↗
Via The Motley Fool
News headline image
CVS Health Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields ↗
 
Via Benzinga
News headline image
Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex' ↗
As President-elect Donald Trump prepares to return to the White House, renowned economist Mohamed El-Erian is cautioning against media oversimplification of the incoming administration's proposed... 
Via Benzinga
Topics Government World Trade
News headline image
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System ↗
PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing. 
Via Benzinga
News headline image
1 Great Reason to Buy Realty Income and Hold It Forever ↗
Via The Motley Fool
News headline image
Analyst Expectations For CVS Health's Future ↗
 
Via Benzinga
News headline image
Smart Money Is Betting Big In CVS Options ↗
 
Via Benzinga
News headline image
CVS Health Stock Is Moving Higher Monday: What's Going On? ↗
CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know. 
Via Benzinga
News headline image
Third Point Hedge Fund Buys Tesla, Dumps Micron ↗
Third Point filed its Form 13F on Thursday, revealing the fund's trades from the prior quarter. 
Via Benzinga
News headline image
2 Beaten-Down Dividend Stocks to Buy and Hold ↗
They're down, but they aren't out, at least not in the eyes of patient investors. 
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
News headline image
Looking for Passive Income? These 3 High-Yield Dividend Stocks Cut You a Check Monthly. ↗
Dividend-paying stocks consistently outperform those that don't pay a dividend. 
Via The Motley Fool
News headline image
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike ↗
The U.S. 
Via Benzinga
News headline image
Dow Jumps Over 1,500 Points To A New High After Trump Win: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone ↗
 
Via Benzinga
Topics Government Stocks
News headline image
Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday? ↗
An “everything rally” powered Wall Street on Wednesday after the 2024 election results, with Donald Trump emerging as the clear presidential winner. 
Via Benzinga
Topics Government
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
72 73 Next >